Case Study: Keepmoat Homes

03.03.2021

Back to News & Resources

This case study outlines how Keepmoat Homes, one of the UK’s top 10 builders of high-quality homes, has started to use fingerprint drug testing across its 100 UK construction sites. The Intelligent Fingerprinting test analyses fingerprint sweat to detect drug use, and will be used by Keepmoat Homes’ Health and Safety Business Partners to manage risk in the area of safety-critical plant operations.

For the full case study, please click on the image below:

Keepmoat Case Study PDF Thumbnail

Related Articles and Resources

View All
Download My Copy
Send